Our thoughts are with the people of Ukraine and those affected across the region. As a global biopharmaceutical company, we have a responsibility to patients who depend on our medicines. We are committed to ensuring our patients in Ukraine, Russia, and throughout the region continue to have access to our essential and life-saving medicines.
As a company dedicated to the health of patients, we will continue to supply our essential life-saving medicines in Russia. All profits from sales of AbbVie’s essential medicines in Russia will be donated to support direct humanitarian relief efforts in Ukraine.
As the tragic events continue to unfold in Ukraine, we previously announced the suspension of operations of our aesthetics products in Russia.
We do not have any manufacturing plants in the region and will continue to monitor the safety of our employees in the region
AbbVie is doing everything possible to minimize disruption to the treatment and care of our patients and clinical trial participants. We have halted new clinical studies and ceased enrollment of ongoing studies in Ukraine and Russia. We are committed to ensuring our clinical trial participants have access to the investigational medicines they need.
Our philanthropic focus is on humanitarian, employee, and donation support.
As this situation evolves, we will continue working with our nonprofit partners and employees to support relief efforts as we hope for a peaceful resolution.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?